May 17th 2024
A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Cannabis for managing menopause symptoms
September 28th 2020This article is based on information presented at the 2020 Virtual Annual Meeting of the North American Menopause Society (NAMS). According to NAMS, all presentations have been pre-recorded and now are available for on-demand viewing beginning Sept. 28 through Sept. 21, 2021.
Read More
Research finds link between prior depression and severity of symptoms during perimenopause
September 18th 2020Perimenopausal women with prior depression exhibit significantly more depressive symptoms, more menopausal symptoms, and more sleep disturbances than perimenopausal women without prior depression, according to a study from Switzerland.
Read More
Variation in outcome reporting and measurement tools among treatment trials for GSM
August 28th 2020Considerable heterogeneity exists in reported outcomes and measures used in clinical trials of treatments for genitourinary syndrome of menopause (GSM), which impacts between 40% and 60% of postmenopausal women, according to a systematic review in the journal Menopause.
Read More
Low BMD linked to periodontitis in perimenopausal women
August 10th 2020A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.
Read More
Subclinical atherosclerosis in postmenopausal women who breastfed
July 27th 2020Postmenopausal women who breastfed for at least 6 months cumulatively have a significantly lower incidence of subclinical atherosclerosis compared to postmenopausal women who breastfeed for a shorter duration, according to a cross-sectional study in the journal Gynecological Endocrinology.
Read More
Early menopause and cardiovascular disease
July 9th 2020The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”
Read More
Vasomotor symptoms and faster epigenetic aging
May 21st 2020Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.
Read More
Impact of vulvovaginal atrophy on sexual function in postmenopausal women
May 13th 2020For postmenopausal women with at least one vulvovaginal atrophy (VVA) symptom, the presence of physician-confirmed VVA is linked to significant impaired sexual function, according to a study from the European Vulvovaginal Epidemiological Survey (EVES).
Read More